ENDPOINTS NEWS11m
As­traZeneca cuts UK fund­ing pledge; Viking says it has ‘enough’ API for tri­als
AstraZeneca cuts UK investment after government reduces site expansion support; Viking secures API supply; Jabil acquires ...
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
ENDPOINTS NEWS38m
As­traZeneca takes $753M charge on aban­doned com­ple­ment drug from Alex­ion deal
AstraZeneca has terminated all development of vemircopan, the oral factor D inhibitor it acquired through the deal for ...
AstraZeneca Boss Says UK ‘Isn’t the Worst Place’ to Invest
The boss of AstraZeneca Plc said he does not believe the UK is the worst place to invest, striking a conciliatory tone just ...